InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,726.80
(
0.25%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.96
(
0.69%
)
Bitcoin
62,590.62
(
1.87%
)

Ambit Biosciences Corp (fka AMBI)

1
Follow
1

Ambit Biosciences Corp (fka AMBI)

1
Follow
1

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up
Live Updating
Newer
profile icon
ECole Free
10/11/13 3:53 AM
Post #1
Last Read
Newer

Ambit Biosciences Corp (fka AMBI) RSS Feed

Followers
1
Posters
15
Posts (Today)
0
Posts (Total)
51
Created
10/11/13
Type
Free
Moderators
Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.
Board Info
Posts Today
0
Posts (Total)
51
Posters
15
Moderators
New Post